Takuma Koike

Dipeptidyl Peptidase-4 Inhibitors Reduced Long-term Cardiovascular Risk in Japanese Diabetic Patients After Percutaneous Coronary Intervention via Insulin-like Growth Factor-1 Axis: A 10-year Follow-up Study

T. Minamino, T. Kasai, T. Dohi, 2021 .

Favorable Prognosis in Patients with Recovered Pulmonary Hypertension after TAVI: An Analysis of the LAPLACE-TAVI Registry

S. Takanashi, T. Minamino, I. Takamisawa, 2023, Journal of clinical medicine.

Long‐term impact of β‐blocker in elderly patients without myocardial infarction after percutaneous coronary intervention

H. Daida, T. Minamino, T. Dohi, 2021, ESC heart failure.

Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study.

H. Daida, S. Suwa, T. Dohi, 2023, Cardiovascular drugs and therapy.

Atypical Shone's Complex Diagnosed at 70 Years Old: Presenting with Double-orifice Mitral Valve, Bicuspid Aortic Valve, and Aortic Coarctation

Kuniaki Hirose, T. Minamino, K. Takamura, 2021, Internal medicine.

Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axis

T. Minamino, T. Kasai, T. Dohi, 2022, Scientific Reports.

Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention

T. Kasai, T. Dohi, S. Okazaki, 2024, Cardiovascular diabetology.